A report from Samsung Bioepis highlighted the positive correlation between biosimilar usage and average sales price discounts, with the oncology space being more price sensitive than other areas.Lower biosimilar prices have resulted in higher market share, with oncology biosimilars bring more price-sensitive than supportive care or immunology biosimilars on the market, according to a new […]